Section 3: Educating and Coaching on Antimicrobial Stewardship (Fellows)
Content in this section is available through 3 communication skills eLearning scenarios. These include:
- Educating and Coaching on AS - Deference to Seniority
- Educating and Coaching on AS - De-escalation and the Outlier Prescriber
- Educating and Coaching on AS - Overly Broad Empiricism
When you are ready to begin:
Ideally, you will begin by reading a brief primer on AS-related communication skills and behavioral psychology.
Next, faculty should lead one or more small group discussions while working through the modules as a group. If faculty resources are unavailable, you may complete the eLearning modules on their own. You should complete module, "Deference to Seniority" first.
This section contains a NARROWS mnemonic and reference pocket card to help you structure and remember AS communication skills to positively influence the prescribing habits of others.
Target Audience
Fellows/Trainees in Antimicrobial Stewardship Training Program
Learning Objectives
Upon completion of this section, you will be able to:
- Explain key behavioral psychology concepts that influence antimicrobial prescribing
- Propose effective techniques to change antimicrobial prescribing practices
- Use provider education techniques to effect change in antimicrobial prescribing
- Demonstrate communication skills to influence antimicrobial prescribing habits of
others
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
Name | Individual's Role in Activity | Name of Commercial Interest | Nature of Relationship |
---|---|---|---|
Abbo, Lillian | Workgroup member | Pfizer Brazil | Honoraria |
Advani, Sonali | Workgroup member | Nabriva Therapeutics | Advisory/Consultant Role |
Amstrong, Wendy | Workgroup member | None | |
Barsoumian, Alice | Workgroup member | None | |
Beeler, Cole | Workgroup member | None | |
Bystritsky, Rachel | Workgroup member | None | |
Cherabuddi, Kartik | Workgroup member | Gatorade | Start - up Research Fund |
NIH (Medimmune) | Research Grant | ||
Cohen, Seth | Workgroup member | None | |
Hamilton, Keith | Workgroup member | None | |
Ince, Dilek | Workgroup member | Ansun Pharma | Research Grant |
Justo, Julie Ann | Workgroup member | None | |
Logan, Ashleigh | Staff | None | |
Luther, Vera | Workgroup member | None | |
Lynch, John | Workgroup member | Astellas Pharmaceuticals, Juno Therapeutics | Advisory/Consultant Role |
Nori, Priya | Workgroup member | None | |
Ohl, Christopher | Workgroup member | Paratek, Bayer, Cempra Pharmaceuticals | Advisory/Consultant Role |
Patel, Payal | Workgroup member | None | |
Pottinger, Paul | Workgroup member | McGraw Hill, Elsevier | Honoraria |
Schwartz, Brian | Workgroup member | None | |
Spicer, Jennifer | Workgroup member | None | |
Stack, Conor | Workgroup member | None | |
Zhou, Yuan | Workgroup member | None | |
Shnekendorf, Rachel | Staff | None |